For instance, Yokobori and colleagues used mesenchymal-correlated CTCs (expression of Plastin 3, a marker that is overexpressed in the mesenchymal status of CTCs in CRC [113]) and its clinical association with the survival of CRC patients [114]. This evidence concerns the gene PLS3 and colorectal carcinoma.